|
ETIOLOGY AND PATHOGENESIS
|
|
|
Barnett CM, Heinrich MC, Lim J, Nelson D, Beadling C, Warrick A, Neff T,
Higano CS, Garzotto M, Qian D, Corless CL, Thomas GV, Beer TM.
Genetic
Profiling to Determine Risk of Relapse-Free Survival in High-Risk Localized
Prostate Cancer.
Clin
Cancer Res. 2014 Feb 6. [Epub ahead of print]
Abstract
| Related
citations
|
|
Moritz R, Ellinger J, Nuhn P, Haese A, Müller SC, Graefen M, Schlomm T,
Bastian PJ.
DNA
hypermethylation as a predictor of PSA recurrence in patients with low- and
intermediate-grade prostate cancer.
Anticancer Res. 2013
Dec;33(12):5249-54.
Abstract
| Related
citations
|
INTEGRATIVE MEDICINE
|
|
|
|
Ax E, Garmo H, Grundmark B, Bill-Axelson A, Holmberg L, Becker W, Zethelius
B, Cederholm T, Sjögren P.
Dietary
Patterns and Prostate Cancer Risk: Report from the Population Based ULSAM
Cohort Study of Swedish Men.
Nutr Cancer. 2014 Jan;66(1):77-87.
doi: 10.1080/01635581.2014.851712. Epub 2013 Dec 10.
Abstract
| Related
citations
|
|
Cao S, Liu L, Yin X, Wang Y, Liu J, Lu Z.
Coffee
consumption and risk of prostate cancer: a meta-analysis of prospective
cohort studies.
Carcinogenesis. 2014 Jan
13. [Epub ahead of print]
Abstract
| Related
citations
|
|
|
Cardwell CR, Flahavan EM, Hughes CM, Coleman HG, O'Sullivan JM, Powe DG,
Murray LJ.
Low-dose
aspirin and survival in men with prostate cancer: a study using the UK
Clinical Practice Research Datalink.
Cancer Causes
Control. 2014 Jan;25(1):33-43. doi: 10.1007/s10552-013-0306-x. Epub
2013 Dec 6.
Abstract
| Related
citations
|
|
|
Fontana L, Adelaiye RM, Rastelli AL, Miles KM, Ciamporcero E, Longo VD,
Nguyen H, Vessella R, Pili R.
Dietary
protein restriction inhibits tumor growth in human xenograft models.
Oncotarget. 2013 Dec;4(12):2451-61.
Abstract | Full text | Related
citations
|
|
|
Flahavan EM, Bennett K, Sharp L, Barron TI.
A
cohort study investigating aspirin use and survival in men with prostate
cancer.
Ann
Oncol. 2014 Jan;25(1):154-9. doi: 10.1093/annonc/mdt428.
Abstract
| Related
citations
|
|
Taneja SS.
Re:
effect of soy protein isolate supplementation on biochemical recurrence of
prostate cancer after radical prostatectomy: a randomized trial.
J Urol. 2014 Jan;191(1):74-6.
doi: 10.1016/j.juro.2013.09.076. Epub 2013 Oct 4.
Abstract
| Full
text | Comment
on | Related
citations
|
|
Taneja SS.
Re:
consumption of fish products across the lifespan and prostate cancer risk.
J Urol. 2014 Jan;191(1):74-5.
doi: 10.1016/j.juro.2013.09.079. Epub 2013 Oct 5.
Abstract
| Full
text | Comment
on | Related
citations
|
|
Zhong S, Chen W, Yu X, Chen Z, Hu Q, Zhao J.
Coffee
consumption and risk of prostate cancer: an up-to-date meta-analysis.
Eur J Clin
Nutr. 2013 Dec 4. doi: 10.1038/ejcn.2013.256. [Epub ahead of print]
Abstract
| Related
citations
|
| NOMOGRAMS |
|
|
|
Briganti A, Karnes RJ, Joniau S, Boorjian SA, Cozzarini C, Gandaglia G,
Hinkelbein W, Haustermans K, Tombal B, Shariat S, Sun M, Karakiewicz PI,
Montorsi F, Van Poppel H, Wiegel T.
Prediction
of Outcome Following Early Salvage Radiotherapy
Among Patients with Biochemical Recurrence After Radical Prostatectomy.
Eur Urol. 2014 Sep 1.
pii: S0302-2838(13)01309-2. doi: 10.1016/j.eururo.2013.11.045. [Epub 2013 Dec
12]
Abstract | Full text | Related
citations
|
|
Lughezzani G, Lazzeri M, Haese A, McNicholas T, de la Taille A, Buffi NM,
Fossati N, Lista G, Larcher A, Abrate A, Mistretta A, Bini V, Redorta JP,
Graefen M, Guazzoni G.
Multicenter
European External Validation of a Prostate Health Index-based Nomogram for
Predicting Prostate Cancer at Extended Biopsy.
Eur Urol. 2013 Dec 16.
pii: S0302-2838(13)01326-2. doi: 10.1016/j.eururo.2013.12.005. [Epub ahead
of print]
Abstract
| Related
citations
|
|
Mearini L, Gacci M, Saleh O, De Nunzio C, Schiavina R, Simonato A, Tubaro A,
Carmignani G, Mirone V, Carini M, Bini V, Porena M.
External
Validation of Nomogram Predicting the Probability of Specimen-Confined
Disease (pT2-3a, R0N0) in Patients Undergoing Radical Prostatectomy and
Pelvic Lymph Node Dissection.
Urol Int. 2013
Dec 14. [Epub ahead of print]
Abstract
| Related
citations
|
ONCOLOGIC OUTCOMES
|
|
|
|
Lin S, Zhang Q, Li P, Li Z, Sun Y, Shao Y, Zhang X, Fu S.
Prediction
of Extraprostatic Extension in Patients with Clinically Organ-Confined
Prostate Cancer.
Urol Int. 2013
Nov 20. [Epub ahead of print]
Abstract
| Related
citations
|
| PROGRESSION |
|
|
Zhao H, Logothetis CJ, Gorlov IP, Zeng J, Dai J.
Modified
logistic regression models using gene coexpression and clinical features to
predict prostate cancer progression.
Comput
Math Methods Med. 2013;2013:917502. doi: 10.1155/2013/917502. Epub
2013 Dec 4.
Abstract | Full text | Related
citations
|
|
RISK STRATIFICATION
|
|
|
Mandel P, Kretschmer A, Chandrasekar T, Nguyen HG, Buchner A, Stief CG,
Tilki D.
The
effect of BMI on clinicopathologic and functional outcomes after open
radical prostatectomy.
Urol Oncol. 2013 Dec 11.
pii: S1078-1439(13)00348-7. doi: 10.1016/j.urolonc.2013.09.005. [Epub ahead
of print]
Abstract
| Related
citations
|
| STATINS |
|
|
|
Moon H, Hill MM, Roberts MJ, Gardiner RA, Brown AJ.
Statins:
protectors or pretenders in prostate cancer?
Trends
Endocrinol Metab. 2014 Jan 22. pii: S1043-2760(13)00215-4. doi:
10.1016/j.tem.2013.12.007. [Epub ahead of print]
Abstract
| Full
text | Related
citations
|
|
SURVIVAL |
|
|
|
De Angelis R, Sant M, Coleman MP, Francisci S, Baili P, Pierannunzio D,
Trama A, Visser O, Brenner H, Ardanaz E, Bielska-Lasota M, Engholm G,
Nennecke A, Siesling S, Berrino F, Capocaccia R; EUROCARE-5 Working Group.
Cancer
survival in Europe 1999-2007 by country and age: results of EUROCARE-5-a
population-based study.
Lancet Oncol. 2014 Jan;15(1):23-34.
doi: 10.1016/S1470-2045(13)70546-1. Epub 2013 Dec 5.
Abstract
| Related
citations
|
|
Hinkelammert R, Eminaga O, Bettendorf O, Eltze E, Abbas M, Hertle L,
Semjonow A.
Tumor
percentage but not number of tumor foci predicts disease-free survival after
radical prostatectomy especially in high-risk patients.
Urol Oncol. 2013 Dec 11.
pii: S1078-1439(13)00405-5. doi: 10.1016/j.urolonc.2013.10.001. [Epub ahead
of print]
Abstract
| Related
citations
|
|
Froehner M, Koch R, Wirth MP, Adam M, Schlomm T, Huland H, Graefen M.
Does
increasing life expectancy affect competing mortality after radical
prostatectomy?
Urol Oncol. 2013 Dec 11.
pii: S1078-1439(13)00446-8. doi: 10.1016/j.urolonc.2013.10.006. [Epub ahead
of print]
Abstract
| Related
citations
|
|
TREATMENT |
|
|
Overviews |
|
Loeb S.
The
age old question: who benefits from prostate cancer treatment?
BJU Int. 2014 Jan;113(1):4.
doi: 10.1111/bju.12184.
Abstract
| Full
text | Related
citations
|
|
Keyes M, Crook J, Morton G, Vigneault E, Usmani N, Morris WJ.
Treatment
options for localized prostate cancer.
Can
Fam Physician. 2013 Dec;59(12):1269-74.
Abstract
| Full
text | Related
citations
|
|
First treatment |
|
Pal SK, Ruel N, Vogelzang N, Chang M, Wilson TG, Jones JO, Yuh B.
Preoperative
Androgen Deprivation Therapy for Localized Prostate Cancer: Delayed
Biochemical Recurrence in High-Risk Disease.
Clin Genitourin
Cancer. 2013 Nov 12. pii: S1558-7673(13)00280-2. doi:
10.1016/j.clgc.2013.11.009. [Epub ahead of print]
Abstract
| Related
citations
|
|
Second-line-treatment |
|
Kowalczyk KJ, Gu X, Nguyen PL, Lipsitz SR, Trinh QD, Lynch JH, Collins SP,
Hu JC.
Optimal
timing of early versus delayed adjuvant radiotherapy following radical
prostatectomy for locally advanced prostate cancer.
Urol Oncol. 2013 Dec 6.
pii: S1078-1439(13)00347-5. doi: 10.1016/j.urolonc.2013.09.004. [Epub ahead
of print]
Abstract
| Related
citations
|
|
Lavallée LT, Fergusson D, Mallick R, Grenon R, Morgan SC, Momoli F, Witiuk
K, Morash C, Cagiannos I, Breau RH
Radiotherapy
after radical prostatectomy: treatment recommendations differ between
urologists and radiation oncologists.
PLoS One. 2013 Nov
4;8(11):e79773. doi: 10.1371/journal.pone.0079773. eCollection 2013.
Abstract
| Full
text | Related
citations
|
|
Shelan M, Abo-Madyan Y, Welzel G, Bolenz C, Kosakowski J, Behnam N, Wenz F,
Lohr F.
Dose-escalated
salvage radiotherapy after radical prostatectomy in high risk prostate
cancer patients without hormone therapy: outcome, prognostic factors and
late toxicity.
Radiat Oncol.
2013 Nov 27;8:276. doi: 10.1186/1748-717X-8-276.
Abstract
| Full
text | Related
citations
|
|
TREATMENT COMPARISON
|
|
|
|
Clyne M.
Prostate
cancer: Open vs laparoscopic vs robotic RP-the biggest study to date.
Nat Rev Urol. 2014
Jan;11(1):6. doi: 10.1038/nrurol.2013.306. Epub 2013 Dec 10.
Abstract
| Related
citations
|
|
|
Sandoval Salinas C, González Rangel AL, Cataño Cataño JG, Fuentes Pachón
JC, Castillo Londoño JS.
Efficacy
of Robotic-Assisted Prostatectomy in Localized Prostate Cancer: A Systematic
Review of Clinical Trials.
Adv Urol.
2013;2013:105651. Epub 2013 Nov 10.
Abstract
| Full
text | Related
citations
|
|
|
Sooriakumaran P, Srivastava A, Shariat SF, Stricker PD, Ahlering T, Eden CG,
Wiklund PN, Sanchez-Salas R, Mottrie A, Lee D, Neal DE, Ghavamian R, Nyirady
P, Nilsson A, Carlsson S, Xylinas E, Loidl W, Seitz C, Schramek P, Roehrborn
C, Cathelineau X, Skarecky D, Shaw G, Warren A, Delprado WJ, Haynes AM,
Steyerberg E, Roobol MJ, Tewari AK.
A
Multinational, Multi-institutional Study Comparing Positive Surgical Margin
Rates Among 22393 Open, Laparoscopic, and Robot-assisted Radical
Prostatectomy Patients.
Eur Urol. 2013 Nov 24.
pii: S0302-2838(13)01215-3. doi: 10.1016/j.eururo.2013.11.018. [Epub ahead
of print]
Abstract
| Full
text | Related
citations
|
TREATMENT DECISION MAKING
|
|
|
Jereczek-Fossa BA, Rodari M, Bonora M, Fanti P, Fodor C, Pepe G, Lopci E,
Zerini D, Vischioni B, Baroni G, Matei DV, De Cobelli O, Chiti A, Orecchia
R.
[11C]Choline
PET/CT Impacts Treatment Decision Making in Patients With Prostate Cancer
Referred for Radiotherapy.
Clin Genitourin
Cancer. 2013 Nov 12. pii: S1558-7673(13)00271-1. doi:
10.1016/j.clgc.2013.11.002. [Epub ahead of print]
Abstract
| Related
citations
|
|
|
|